New Feature Coming Soon, Stay Tuned!
Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
NYSE
Unprofitable
Unprofitable
0.02Â ( 0.14%)
Pre-market 14.27$0.16 (1.13%)
Relative Strenght
0
Volume Buzz
-24%
Earning Acce
No
Dist 52w H.
75%